Starpharma Holdings Ltd
ASX:SPL
Starpharma Holdings Ltd
Cash from Operating Activities
Starpharma Holdings Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Starpharma Holdings Ltd
ASX:SPL
|
Cash from Operating Activities
-AU$6.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Operating Activities
-AU$42.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Operating Activities
AU$184.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Operating Activities
-AU$10.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-29%
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Operating Activities
AU$15.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Operating Activities
-AU$27.5m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Starpharma Holdings Ltd's Cash from Operating Activities?
Cash from Operating Activities
-6.4m
AUD
Based on the financial report for Dec 31, 2023, Starpharma Holdings Ltd's Cash from Operating Activities amounts to -6.4m AUD.
What is Starpharma Holdings Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-1%
Over the last year, the Cash from Operating Activities growth was 9%. The average annual Cash from Operating Activities growth rates for Starpharma Holdings Ltd have been 17% over the past three years , and -1% over the past ten years .